Virtual Roundtable on Diversity in Clinical Trial Enrollment


The Society for Immunotherapy of Cancer (SITC) invites you to attend the virtual Roundtable on Diversity in Clinical Trial Enrollment.

The goal of the roundtable is to develop recommendations for specific actions each stakeholder in the clinical trial ecosystem can take to positively impact diversity in clinical trial enrollment. Representatives from each stakeholder group will participate in the roundtable, which will consist of a series of presentations and panels that highlight success stories and lessons learned in addressing implicit bias challenges, creating patient and community engagement and optimizing trial designs and operations that facilitate access to clinical trials for patients of diverse backgrounds. By enabling a conversation across stakeholders, SITC aims to carve a roadmap for next steps each stakeholder group can take to increase diversity in all immuno-oncology clinical trials.

Open access to the roundtable recording can be found here. 


Roundtable Agenda

Tuesday, July 25  |  3–6:10 p.m. ET

Welcome

3:00–3:05 p.m.

Leisha A. Emens, MD, PhD
Ankyra Therpeutics

Setting the Stage

3:05–4:05 p.m.

Moderator
Leisha A. Emens, MD, PhD
Ankyra Therpeutics

3:05–3:15 p.m.

Patient Perspective
Mel Mann, MBA, MEd

3:15–3:25 p.m. 

Implicit Bias 
Mona Fouad, MD, MPH
University of Alabama at Birmingham

3:25–3:40 p.m.

Success Story - Sponsor Perspective 
Shalini Mohan, MD
Genentech

3:40–3:55 p.m.

Success Story - Community Perspective
Augusto Ochoa, MD
Louisiana State University Health Sciences Center

3:55–4:05 p.m.

Break

4:05–4:35 p.m.

Implicit Bias: Broadening the Lens

Moderator
Chelsea C. Pinnix, MD, PhD
The University of Texas MD Anderson Cancer Center

Speakers

Curtiland Deville, MD
Johns Hopkins University of Medicine

Chika Madu, MD
Staten Island University Hospital at Northwell Health

Benjamin Schrank, MD, PhD
MD Anderson Cancer Center

Panel 1

4:35–5:20 p.m

Patient and Community Engagement

Moderator
John H. Stewart IV, MD, MBA, FACS 
LSU-LCMC Health Cancer Center

 

Panelists

Melissa Buffalo, MS
American Indian Cancer Foundation 

Oluwadamilola Fayanju, MD, MA, MPHS, FACS
University of Pennsylvania

Mona Fouad, MD, MPH, UAB
University of Alabama at Birmingham

Mel Mann, MBA, MEd

Cristin MacDonald
WCG Clinical

Luckson Mathieu, MD
Food and Drug Administration (FDA)

 

Ryan J. Sullivan, MD
Harvard Medical School, Massachusetts General Hospital

Panel 2

5:20–6:05 p.m. 

Trial Complexity vs. Standard of Care

Moderator
Michael Morris, MD
Memorial Sloan Kettering Cancer Center

Panelists

Leila Hamroun-Yazid, AIA, NCARB. LEED AP Founding Member, OPACT Group
Tetra Tech Architects & Engineers, Algerian American Foundation

Jasmine Kamboj, MD, MBBS
Mayo Clinical Health System

Luckson Mathieu, MD
Food and Drug Administration (FDA)

Shalini Mohan, MD
Genentech

Margaret Mooney, MD
National Cancer Institute

Ishwaria Subbiah, MD
Sarah Cannon Research Institute (SCRI)

Desirée Walker

Summary & Next Steps

6:05–6:10 p.m.

Leisha A. Emens, MD, PhD
Ankyra Therpeutics

Virtual Roundtable Organizers


Leisha A. Emens, MD, PhD

Ankyra Therapeutics 


Chelsea C. Pinnix, MD, PhD

The University of Texas MD Anderson Cancer Center


Padmanee Sharma, MD, PhD

The University of Texas MD Anderson Cancer Center

John H. Stewart IV, MD, MBA, FACS


John H. Stewart IV, MD, MBA, FACS

LSU-LCMC Health Cancer Center